<h2>THE COKE IN COCA-COLA</h2> If our economy tanked because of subprime mortgages, perhaps the time has come to look at subprime drugs. (I’d call drugs “subprime” if they affect bodily functions without having undergone tests of safety and efficacy by the FDA.) Unfortunately, the $24 billion/year “dietary supplement” industry peddles subprime concoctions that can only be recalled after someone blows a whistle. Case in point: A highly publicized lawsuit filed by the Falcons’ Grady Jackson preceded a manufacturer’s recall of StarCaps slimming capsules and manufacturer recalls of more than 60 other dietary supplements. Among the covert ingredients of these over-the-counter nostrums was bumetanide, a potent diuretic (5) ⇓ . This was not the first time a court in Atlanta has heard accusations of hidden ingredients in a patent medicinal. In 1902, an Atlanta courtroom heard evidence that a medicinal “stimulant,” Coca-Cola, was liberally laced with caffeine and undetermined amounts of cocaine. The ensuing uproar over secret components, especially cocaine, in patent medicines led to passage of the Pure Food and Drug Act of 1906, provisions of which still guide the FDA. Follow-up litigation ensured that today’s Coke no longer contains coke (6) ⇓ . The 1902 trial in
End of preview. The entire article is 4 pages. To view the full-text, please rent this article to continue.
/lp/fed-of-american-socs-for-experimental-biology/the-atlanta-falcon-and-tono-bungay-dietary-supplements-as-subprime-6pMYQjJCZY
Welcome to DeepDyve! Rent Premier Research Articles and Save Up to 90%
The Atlanta Falcon and Tono-Bungay: Dietary Supplements as Subprime Drugs
Weissmann, Gerald
Follow The FASEB Journal
, Volume 23 (5): 1279
Fed of American Socs for Experimental Biology – May 1, 2009
More Info
More Like This Article
View All dataSource[]=actageo&dataSource[]=aspet&dataSource[]=aaos&dataSource[]=aacc&dataSource[]=aacr&dataSource[]=aea&dataSource[]=aip&dataSource[]=ajnr&dataSource[]=ams&dataSource[]=aps_physical&dataSource[]=appi_book&dataSource[]=appi_journal&dataSource[]=apha&dataSource[]=asip&dataSource[]=asm&dataSource[]=asn&dataSource[]=aspb&dataSource[]=avs&dataSource[]=annual_reviews&dataSource[]=arxiv&dataSource[]=acm&dataSource[]=berghahn&dataSource[]=cabi&dataSource[]=clinical_trials&dataSource[]=dailymed&dataSource[]=degruyter&dataSource[]=du_press&dataSource[]=esa&dataSource[]=eu_press&dataSource[]=elsevier&dataSource[]=emerald&dataSource[]=ejtr&dataSource[]=emea&dataSource[]=epo&dataSource[]=faseb&dataSource[]=gsa&dataSource[]=health_affairs&dataSource[]=hindawi&dataSource[]=imanager&dataSource[]=imedpub&dataSource[]=informa_healthcare&dataSource[]=informs&dataSource[]=iop&dataSource[]=iucr&dataSource[]=iospress&dataSource[]=jbjs&dataSource[]=leftcoast&dataSource[]=lu_press&dataSource[]=mesharpe&dataSource[]=mary_ann_liebert&dataSource[]=medline&dataSource[]=mit_press&dataSource[]=nature&dataSource[]=oxford&dataSource[]=pier_professional&dataSource[]=pnas&dataSource[]=portlandpress&dataSource[]=psyc_articles&dataSource[]=psyc_books&dataSource[]=psyc_critiques&dataSource[]=plos_journal&dataSource[]=pubmed_central&dataSource[]=rsna&dataSource[]=rockefeller&dataSource[]=rcn&dataSource[]=ria&dataSource[]=rsc&dataSource[]=sage&dataSource[]=spie&dataSource[]=springer_journal&dataSource[]=springer&dataSource[]=taylor_francis&dataSource[]=aps&dataSource[]=the_scientist&dataSource[]=uc_press&dataSource[]=uspto_abstract&dataSource[]=wiley&dataSource[]=pct
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy
